Isomorphic Labs raises $7.1B in six months for drug discovery
What happened
On Nov 17 TechCrunch reported that Isomorphic Labs raised a $5 billion Series C to push drug candidates into clinical trials, with the money going to further develop its AI drug design engine and expand the types of drugs it works on. The Decoder then reported that the round at the Alphabet-owned AI drug discovery company was co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz, Alphabet and all existing investors taking part. The company raised $2.1 billion in May 2026, making this its second billion-dollar round in six months, for $7.1 billion across the two.
Written by AI from the coverage · updated 3 days ago
Coverage
Follow the reports to see the story from different sides.
- The DecoderIsomorphic Labs raises $5 billion in its second mega-round within six months
Alphabet 旗下 AI 药物发现公司 Isomorphic Labs 融资 $5 billion,这是其六个月内第二轮十亿美元级融资。Greenoaks 和 Sequoia Capital 联合领投,Andreessen Horowitz、Alphabet 及所有现有投资者参与,公司此前于 2026 年 5 月融资 $2.1 billion。
- TechCrunch · AIPickIsomorphic Labs raises $5 billion to push drug candidates toward clinical trials
Isomorphic Labs closed a $5 billion Series C round. The money goes toward moving its drug candidates into clinical trials, continuing work on its AI drug design engine and expanding the types of drugs it targets.
Heat over time
Heat now 5·Comparable peak 19(Nov 18 00:00)·Comparable change over 24 hours -50%
The trend only compares accounts observed without gaps, so its range may be smaller than the current heat. Hover or tap the chart for each hour; the left and right arrow keys step through it.